# BlackRock Throgmorton achieves another month outperforming its benchmark

- Link: https://www.directorstalkinterviews.com/blackrock-throgmorton-achieves-another-month-outperforming-its-benchmark/4121130771
- Published: 2023-10-26T08:55:23+01:00
- Author: Amilia Stone

**[BlackRock Throgmorton](https://www.directorstalkinterviews.com/company/blackrock-throgmorton-trust-plc/thrg.l)
Trust plc** ([LON:THRG](https://www.directorstalkinterviews.com/company/blackrock-throgmorton-trust-plc/thrg.l))
has announced its portfolio update.

All information is at **30 September 2023** and unaudited.

**To learn more about the BlackRock Throgmorton Trust plc please follow this link:**
[**blackrock.com/uk/thrg**](https://www.blackrock.com/uk/solutions/investment-trusts/our-range/blackrock-throgmorton-investment-trust/trust-information?siteEntryPassthrough=true&cid=aff%3Ainvestmenttrusts2020%3Athrg%3Adirectorstalk%3Alink)

**Performance at month end is calculated on a cum income basis**

|  | **One**
**Month****%** | **Three****months****%** | **One****year****%** | **Three****years****%** | **Five****years****%** | 
| Net asset value | -0.3 | -0.5 | 13.2 | 4.5 | 9.4 | 
| Share price | 2.5 | 0.1 | 14.1 | 2.4 | 13.3 | 
| Benchmark* | -1.6 | -1.3 | 3.3 | 9.9 | -1.0 |

Sources: BlackRock and Datastream

*With effect from 22 March 2018 the Numis Smaller Companies plus AIM (excluding 
Investment Companies) Index replaced the Numis Smaller Companies excluding AIM (
excluding Investment Companies) Index as the Company’s benchmark. The performance
of the indices have been blended to reflect this.

| **At month end** | 
| Net asset value capital only: | 595.12p | 
| Net asset value incl. income: | 606.28p | 
| Share price | 573.00p | 
| Discount to cum income NAV | 5.5% | 
| Net yield^(1): | 2.1% | 
| Total Gross assets^(2): | £592.0m | 
| Net market exposure as a % of net asset value^(3): | 108.6% | 
| Ordinary shares in issue^(4): | 97,639,597 | 
| 2022 ongoing charges (excluding performance fees)^(5,6): | 0.54% | 
| 2022 ongoing charges ratio (including performance
fees)^(5,6,7): | 0.54% |

1. Calculated using the 2022 final dividend declared on 10 February 2023 and paid
on 31 March 2023, together with the Interim Dividend declared on 07 July 2023 paid
on 29 August 2023.

2. Includes current year revenue and excludes gross exposure through contracts for
difference.

3. Long exposure less short exposure as a percentage of net asset value.

4. Excluding 5,570,267 shares held in treasury.

5. The Company’s ongoing charges are calculated as a percentage of average daily
net assets and using the management fee and all other operating expenses, excluding
performance fees, finance costs, direct transaction charges, VAT recovered, taxation
and certain other non-recurring items for the year ended 30 November 2022.

6. With effect from 1 August 2017 the base management fee was reduced from 0.70%
to 0.35% of gross assets per annum. The Company’s ongoing charges are calculated
as a percentage of average daily net assets and using the management fee and all
other operating expenses, including performance fees, but excluding finance costs,
direct transaction charges, VAT recovered, taxation and certain other non-recurring
items for the year ended 30 November 2022.

7. Effective 1st December 2017 the annual performance fee is calculated using performance
data on an annualised rolling two-year basis (previously, one year) and the maximum
annual performance fee payable is effectively reduced to 0.90% of two year rolling
average month end gross assets (from 1% of average annual gross assets over one 
year). Additionally, the Company now accrues this fee at a rate of 15% of outperformance(
previously 10%). The maximum annual total management fees (comprising the base management
fee of 0.35% and a potential performance fee of 0.90%) are therefore 1.25% of average
month end gross assets on a two-year rolling basis (from 1.70% of average annual
gross assets).

| **Sector Weightings** | **% of Total Assets** | 
|   |   | 
| Industrials | 32.0 | 
| Consumer Discretionary | 24.4 | 
| Financials | 14.3 | 
| Technology | 8.3 | 
| Basic Materials | 5.2 | 
| Health Care | 3.7 | 
| Telecommunications | 3.2 | 
| Consumer Staples | 2.8 | 
| Communication Services | 2.3 | 
| Energy | 1.4 | 
| Real Estate | 1.0 | 
| Net Current Assets | 1.4 | 
|   | —– | 
| **Total** | 100.0 | 
|  | ===== | 
|  |   | 
| **Country Weightings** | **% of Total Assets** | 
|   |   | 
| United Kingdom | 94.7 | 
| United States | 2.6 | 
| Australia | 0.8 | 
| France | 0.7 | 
| Ireland | 0.7 | 
| Netherlands | 0.5 | 
| Switzerland | 0.4 | 
| Sweden | -0.4 | 
|   | —– | 
| **Total** | 100.0 | 
|   | ===== |

| **Market Exposure (Quarterly)** | 
|  | 
|  | **30.11.22**
**%** | **28.02.23****%** | **31.05.23****%** | **31.08.23****%** | 
| Long | 105.8 | 110.3 | 111.7 | 112.7 | 
| Short | 2.5 | 2.3 | 3.6 | 4.5 | 
| Gross exposure | 108.3 | 112.6 | 115.3 | 117.2 | 
| Net exposure | 103.3 | 108.0 | 108.1 | 108.2 |

| **Ten Largest Investments** | 
|  | 
| **Company** | **% of Total Gross Assets** | 
|  |   | 
| Gamma Communications | 3.2 | 
| 4imprint Group | 3.1 | 
| Grafton Group | 3.0 | 
| Breedon | 2.9 | 
| WH Smith | 2.7 | 
| CVS Group | 2.6 | 
| Rotork | 2.5 | 
| Oxford Instruments | 2.5 | 
| Computacenter | 2.3 | 
| YouGov | 2.3 | 
|   |   |

**Commenting on the markets, Dan Whitestone, representing the Investment Manager
noted:**

The Company returned -0.5% in September, outperforming the Numis Smaller Companies
plus AIM (excluding Investment Companies) benchmark which returned -1.6%.

September proved another challenging month to navigate with small & mid-caps in 
the UK continuing to underperform large caps ([FTSE 250](https://www.directorstalkinterviews.com/news/ftse-250)
Index -1.5% vs [FTSE 100](https://www.directorstalkinterviews.com/news/ftse-100)
Index 2.4%) amidst rising energy prices and surging bond yields. The “higher for
longer” narrative gained momentum on the back of several US economic data points
as well as hawkish comments from several Federal Open Market Committee (FOMC) members.
On the ground, economic growth continues to show resilience, though there are emerging
signs of weakness amidst the US consumer (decrease in excess savings, and a rise
in US credit delinquencies for instance) which may in turn give the Federal Reserve
pause for thought.

The biggest contributor was Ergomed which announced a recommended cash offer from
the Private Equity firm, Permira, at a 28% premium to the previous day’s closing
price. Whilst helpful to this month’s performance we will be disappointed to lose
another one of our genuinely differentiated UK mid-cap growth companies. However,
in our view Ergomed is another example of the inherent value within the broader 
UK mid-cap complex (and our long book!), where many predominantly international 
earners continue to grow, with strong balance sheets, yet trade on significant valuation
discounts to their US listed peers. The second biggest contributor was Computacenter,
which rallied after reporting better than expected numbers, delivering an impressive
24% year-on-year growth in organic revenues in H123 as they benefit from ongoing
digital transformation programmes and market share gains. The third biggest contributor
was Kier Group, which delivered FY23 results slightly ahead of consensus and announced
their plans to return to paying a dividend, reflecting the strength of their cashflows
and balance sheet. Considering the shares were trading on just over 4x this year’s
earnings, they rallied strongly.

The largest detractor was CVS Group, which fell 25% on the news that the CMA (Competition
and Markets Authority) are launching an inquiry into how “veterinary services are
bought and sold amid concerns that pet owners may not be getting a good deal or 
receiving the information that need to make good choices”. Whilst we have spoken
to Management at length and also have experience of CMA inquiries into other industries,
due to the sensitivity of this we feel it imprudent to comment now. The second biggest
detractor was YouGov, which fell sharply through the month reflecting a growing 
fear of an imminent profit warning. However, YouGov reported solid results in early
October (post month end) and the shares subsequently rallied which will be captured
in October’s performance. The third largest detractor was WH Smith which reported
solid trading, however the shares fell back, perhaps on the lack of an upgrade to
full-year guidance.

To recap, September was a difficult month, but we think another month finishing 
ahead of our benchmark is a creditable outcome. The last couple of months have certainly
presented their challenges, but we continue to feel confident in the Company’s positioning,
overall balance, and the increasing role that stock specifics are having. We retain
the strong view that there are many significant mis-pricings in the market, and 
we continue to see lots of exciting opportunities. Despite our optimism in the prospects
for holdings within the portfolio, we remind ourselves that the backdrop remains
volatile, and this is reflected in the gross and net which remain around 116% and
108% respectively.

^(1)Source: BlackRock as at 30 September 2023

**To learn more about the BlackRock Throgmorton Trust plc please follow this link:**
[**blackrock.com/uk/thrg**](https://www.blackrock.com/uk/solutions/investment-trusts/our-range/blackrock-throgmorton-investment-trust/trust-information?siteEntryPassthrough=true&cid=aff%3Ainvestmenttrusts2020%3Athrg%3Adirectorstalk%3Alink)

Share on:
